BAKAY, Umut; İZCI DURAN, Tuğba. Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort. Archives of Rheumatology, [S. l.], v. 40, n. 4, p. 465–473, 2025. DOI: 10.5152/ArchRheumatol.2025.11098. Disponível em: https://www.archivesofrheumatology.org/index.php/pub/article/view/1520. Acesso em: 6 dec. 2025.